Skip to content
Clinical Trials – home

Highly Refined Fish Oil: A Promising Treatment for Cardiac Surgery Patients and Acute Pancreatitis

2 / 2
trials open to patients / all trials
3+
Countries

In short

Highly Refined Fish Oil is emerging as a promising treatment in various medical conditions. This article explores two significant clinical trials investigating its use in cardiac surgery patients and those with severe acute pancreatitis. These studies aim to evaluate the potential benefits of fish oil in reducing complications and improving patient outcomes in critical care settings.

What is Highly Refined Fish Oil?

Highly refined fish oil is a medical product derived from fish that contains high concentrations of omega-3 fatty acids. It is being studied as a potential treatment for various medical conditions, particularly in critically ill patients and those undergoing cardiac surgery. This substance is often referred to as "long chain omega-3-fatty acids" in medical contexts.

Potential Benefits for Cardiac Surgery Patients

Research is being conducted to explore the potential benefits of highly refined fish oil for patients undergoing high-risk cardiac surgery. The primary focus is on its ability to prevent atrial fibrillation (an irregular and often rapid heart rate) after surgery. Some potential benefits being studied include:

  • Prevention of atrial fibrillation up to 7 days after surgery
  • Enhanced recovery after cardiac surgery
  • Reduced time to discharge from the hospital
  • Improved organ function
  • Shorter stays in the intensive care unit (ICU) and hospital
  • Reduced need for mechanical ventilation
  • Lower incidence of stroke
  • Improved kidney function
  • Better overall survival rates

Potential Benefits for Acute Pancreatitis Patients

Another area of research is exploring the use of highly refined fish oil in patients with predicted severe acute pancreatitis. The main goal is to reduce organ failure and mortality in these patients. Potential benefits being investigated include:

  • Reduction in new organ failure (cardiovascular, pulmonary, or renal)
  • Lower mortality rates
  • Fewer infectious complications
  • Reduced need for surgical, endoscopic, or radiologic interventions
  • Shorter hospital and ICU stays
  • Decreased levels of C-reactive protein (CRP), an indicator of inflammation

How is it Administered?

Highly refined fish oil is typically administered intravenously (through a vein) as an emulsion for infusion. The dosage and duration of treatment may vary depending on the specific condition being treated and the individual patient's needs. For example:

  • In cardiac surgery patients, it may be given at a dose of up to 200,000 μg/kg per day for up to 8 days.
  • In acute pancreatitis patients, it might be administered at 2 ml/kg/day for up to 7 days.

Who Can Receive This Treatment?

The use of highly refined fish oil is still being researched, and specific criteria determine who might be eligible for these treatments. Generally, candidates may include:

  • Adult patients (18 years or older) undergoing high-risk cardiac surgery
  • Patients with predicted severe acute pancreatitis

However, certain factors may exclude a patient from receiving this treatment, such as:

  • Known allergies to fish oil, fish products, or egg protein
  • Severe liver or kidney dysfunction
  • Pregnancy or breastfeeding
  • Recent history of certain medical conditions (e.g., heart attack, stroke)
  • Participation in other clinical trials

Possible Side Effects and Precautions

As with any medical treatment, there may be potential side effects or risks associated with highly refined fish oil. These may include:

  • Allergic reactions, especially in people with known allergies to fish or egg products
  • Increased risk of bleeding in patients with coagulation disorders
  • Potential interactions with other medications

It's important to discuss any concerns or potential risks with your healthcare provider before considering this treatment.

Ongoing Research

The use of highly refined fish oil in critical care and surgical settings is an active area of research. Clinical trials are ongoing to better understand its effectiveness, optimal dosing, and potential benefits for various patient groups. As more data becomes available, our understanding of this treatment's role in patient care will continue to evolve.

Questions people often ask

Conditions where Highly Refined Fish Oil is being studied

Each condition opens its own overview and trial list

Trials with Highly Refined Fish Oil

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).